Penguins, Asian elephants and many other animal species live in the zoos of Saarbrücken and Neunkirchen. As they come from different continents, blood is regularly taken from the animals to check their health. These blood samples have now been used by bioinformaticians and human geneticists ... more
Hummingbird Diagnostics and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers
Hummingbird Diagnostics GmbH, specialized in early disease detection using molecular markers derived from blood, and Saarland University agreed on a comprehensive framework agreement regarding an expanded collaboration in the field of molecular diagnostics. The work aims at the validation of miRNA biomarkers in blood samples, allowing for an early detection of common serious diseases including lung cancer, chronic obstructive lung disease (COPD), Alzheimer's and Parkinson's.
The project partners at Saarland University are the Department of Human Genetics and the Chair of Clinical Bioinformatics. Hummingbird Diagnostics has been maintaining long-standing research collaborations with both their renowned directors, Prof. Dr. Andreas Keller (Clinical Bioinformatics) and Prof. Dr. Eckart Meese (Human Genetics).
Since 2009, the two miRNA experts have been working together successfully in projects involving several disease areas. This partnership resulted in more than 60 scientific publications as well as a multitude of patents.
The Vice President of Saarland University, Prof. Dr. Martina Sester, appreciates the collaboration: "With Hummingbird Diagnostics, we acquired an excellent partner, enabling us to translate the outstanding research of Profs. Keller and Meese into clinical applications, thus generating significant future benefit for many patients."
Prof. Dr. Andreas Keller, Director of the Chair of Clinical Bioinformatics comments: „We know Hummingbird Diagnostics as an innovative and reliable partner with unique expertise in miRNA biomarkers from body fluids. Therefore, we are pleased to further expand the collaboration, allowing us to validate our research results and translate them into clinical practice.“ His colleague Prof. Dr. Meese adds: „Moreover, this collaboration enables a better understanding of the functional mechanisms of biomarkers, an aspect of increasing importance in diagnostics.“
„Together with the teams of Prof. Dr. Keller and Prof. Dr. Meese, we successfully identified many miRNAs from blood that may contribute to patient-friendly methods for early disease detection,“ says Jochen Kohlhaas, CEO of Hummingbird Diagnostics. „The new agreement enables us to collaboratively address further disease areas, such as neurodegenerative diseases.“
The partners envisage to examine at least 5.000 samples from patients with pulmonary diseases (COPD, lung cancer) and neurodegenerative conditions (Parkinson's and Alzheimer's). The framework agreement regulates the procedures of collaborative projects as well as the utilization of results, publications, software, and intellectual property rights. Within the agreement, Hummingbird Diagnostics acquired the rights in eight further patents.
- molecular diagnostics
The thinnest materials that can be produced today have the thickness of a single atom. These materials – known as two-dimensional materials – exhibit properties that are very different compared with their bulk three-dimensional counterparts. Until recently, 2D materials were produced and ma ... more
NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is used to help with the characterization of polymeric nanoparticles synthesized as drug carrier systems. This work is being carried out at Saarland University by Dr Christian Ruge and his colleagues. In the world of pharmaceutic ... more
- 1analytica 2020: World’s leading trade fair to be held virtually
- 2analytica 2020: The world’s leading trade fair extends its reach with analytica virtual
- 3Portable, point-of-care COVID-19 test could bypass the lab
- 4Researchers dramatically downsize technology for fingerprinting drugs and other chemicals
- 5Attacking tumours directly on identification
- 6Towards a cell-based interceptive medicine in Europe
- 7Giant nanomachine aids the immune system
- 8A tiny instrument to measure the faintest magnetic fields
- 9Leap forward in the fight against antibiotic resistance
- 10New device can measure toxic lead within minutes